Researchers at the Technion, led by Professor Ester Segal of the Faculty of Biotechnology and Food Engineering, and researchers at Bar Ilan University, have developed new technology for transporting drugs within silicon nanostructures to the brain.
These nanostructures release an essential protein, which can inhibit the development of Alzheimer’s disease, and provide targeted delivery in the brain with the use of a “gene gun.” The research was conducted with the support of the Russell Berrie Nanotechnology Institute at the Technion.